Environment &
Food & Beverage
Cosmetics
Life Sciences
Metal & Mining Industry
Petrochemical & General Chemistry
Automotive Related & Interior Materials
Applications including "InertSustain C18"
-
LT207 - Anaysis of Antioxidant capacity by post-column HPLC using DPPH radical -
LC Technical Note InertSustain C18 -
LT204 - Validity evaluation of methidathione oxone in tap water using LC-MS/MS -
LC Technical Note InertSustain C18 -
LT203 - Analysis of cyclosporin A in serum using MonoSpin C18 and Ph. -
LC Technical Note InertSustain Phenyl -
LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -
LC Technical Note InertSustain AQ-C18 InertSustain PFP -
LT200 - InertSustain & Inertsil HPLC Columns for Reversed Phase Separation -
LC Technical Note InertSustain C18 InertSustain AQ-C18 InertSustainSwift C18 InertSustain AX-C18 Inertsil ODS-HL Inertsil ODS-4 Inertsil ODS-3 Inertsil ODS-P Inertsil ODS-EP InertSustain C8 Inertsil C8-4 Inertsil C4 Inertsil WP300 C18 Inertsil WP300 C8 Inertsil WP300 C4 InertSustain PFP InertSustain Phenyl InertSustain Phenylhexyl -
LT197 - Analysis of capsaicin by HPLC and LC/MS/MS -
LC Technical Note InertSustain C18 -
LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -
LC Technical Note InertSustain AQ-C18 -
ST030 - Analysis of cyromazine in livestock products -
SPE Technical Note InertSustain C18 -
ST029 - Analysis of Kasugamycin -
SPE Technical Note InertSep C18 InertSustain Amide -
LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -
LC InertSearch InertSustain C18 -
LB043 - Analysis of 18Drugs(InertSustain C18 HP) -
LC InertSearch InertSustain C18 -
LA974 - Analysis of Non-ionic surfactant(Detected by Pre-Column complexation with Co-PAR) -
LC InertSearch InertSustain C18 -
LA911 - Analysis of 16 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA907 - Analysis of Water-soluble Vitamins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA901 - Analysis of linear fatty acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA894 - Analysis of organic acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -
LC InertSearch InertSustain AQ-C18 -
LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -
LC InertSearch InertSustainC18 -
LC106 - Analysis of Sodium Dodecyl Sulfate(Sodium lauryl sulfate) -
LC InertSearch InertSustain C18 -
LC105 - Analysis of Cefalexin (Under the Condition of Japanese Pharmacopoeia 18th, Cefalexin,Purity(3) Related substances ) -
LC InertSearch InertSustainSwift C18 -
LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -
LC InertSearch InertSustainSwift C18 -
LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -
LC InertSearch InertSustainSwift C18 -
LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -
LC InertSearch InertSustain C18 -
LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -
LC InertSearch InertSustain C18 -
LC065 - Analysis of Vitamin E (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 1) -
LC InertSearch InertSustain C18 -
LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -
LC InertSearch InertSustainSwift C18 -
LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -
LC InertSearch InertSustainSwift C18 -
LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -
LC InertSearch InertSustain C18 -
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -
LC InertSearch InertSustain AQ-C18 -
LC058 - Analysis of Folic acid (Under the Condition of USP NF 2022 ISSUE 3, <411>FOLIC ACID ASSAY,_Procedure 1) -
LC InertSearch InertSustainSwift C18 -
LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -
LC InertSearch InertSustain C18 -
LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -
LC InertSearch InertSustain C18 -
LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -
LC InertSearch InertSustain C18 -
LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -
LC InertSearch InertSustain AQ-C18 -
LC049 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 2) -
LC InertSearch InertSustain C18 -
LC047 - Analysis of Homocysteine -
LC InertSearch InertSustain AQ-C18 -
LC044 - Analysis of Calcium Pantothenate (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Calcium Pantothenate, Method1) -
LC InertSearch InertSustainSwift C18 -
LC043 - Analysis of Semaglutide and Tirzepatide -
LC InertSearch InertSustainSwift C18 -
LC041 - Analysis of Nicotinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method1 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method1) -
LC InertSearch InertSustain C18 -
LC038 - Analysis of Brilliant Green and Methylene Blue -
LC InertSearch InertSustain C18 -
LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -
LC InertSearch InertSustain C18 -
LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -
LC InertSearch InertSustain C18 -
LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -
LC InertSearch InertSustain C18 -
LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -
LC InertSearch InertSustain C18 -
LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -
LC InertSearch InertSustain C18 -
LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -
LC InertSearch InertSustain C18 -
LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -
LC InertSearch InertSustain C18 -
LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -
LC InertSearch InertSustain C18 -
LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -
LC InertSearch InertSustain C18 -
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -
LC InertSearch InertSustain AQ-C18 -
LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -
LC InertSearch InertSustain C18 -
LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -
LC InertSearch InertSustain C18 -
LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -
LC InertSearch InertSustain C18 -
LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -
LC InertSearch InertSustain C18 -
LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -
LC InertSearch InertSustain C18 -
LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -
LC InertSearch InertSustain C18 -
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -
LC InertSearch InertSustain C18 -
LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -
LC InertSearch InertSustainSwift C18 -
LC013 - Analysis of Bleomycin sulfate -
LC InertSearch InertSustain AQ-C18 -
LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -
LC InertSearch InertSustain C18 -
LC005 - Carbamazepine -
LC InertSearch InertSustainSwift C18 -
LC004 - Analysis of Urea and Thiourea -
LC InertSearch InertSustain AQ-C18 -
LC002 - Analysis of Phenazopyridine hydrochloride -
LC InertSearch InertSustain C18 -
LB989 - Analysis of Xylazine -
LC InertSearch InertSustain C18 -
LB988 - Analysis of Xylazine -
LC InertSearch InertSustainSwift C8 -
LB984 - Analysis of Sumatriptan -
LC InertSearch InertSustain AQ-C18 -
LB982 - Analysis of Ofloxacin -
LC InertSearch InertSustain C18 -
LB980 - Analysis of Desloratadine -
LC InertSearch InertSustain AQ-C18 -
LB979 - Analysis of Desloratadine -
LC InertSearch InertSustain Cyano -
LB978 - Analysis of Hydrochlorothiazide -
LC InertSearch InertSustain AQ-C18 -
LB977 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain AQ-C18 -
LB976 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB975 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB974 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB973 - Analysis of Dapagliflozin propandiol -
LC InertSearch InertSustain C18 -
LB972 - Analysis of Acyclovir -
LC InertSearch InertSustain C18 -
LB971 - Analysis of Acyclovir -
LC InertSearch InertSustain C18 -
LB970 - Analysis of Acyclovir -
LC InertSearch InertSustain C18 -
LB969 - Analysis of Acyclovir -
LC InertSearch InertSustainSwift C18 -
LB967 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -
LC InertSearch InertSustain AQ-C18 -
LB962 - Analysis of β-carotene -
LC InertSearch InertSustainSwift C18 -
LB959 - Analysis of Food Dyes -
LC InertSearch InertSustainSwift C18 -
LB955 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -
LC InertSearch InertSustain AX-C18 -
LB954 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -
LC InertSearch InertSustain AQ-C18 -
LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -
LC InertSearch InertSustain C18 -
LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -
LC InertSearch InertSustain C18 -
LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -
LC InertSearch InertSustain C18 -
LB947 - Analysis of Glacial Acetic Acid -
LC InertSearch InertSustain AQ-C18 -
LB946 - Analysis of Glacial Acetic Acid -
LC InertSearch InertSustain AQ-C18 -
LB945 - Analysis of Glacial Acetic Acid -
LC InertSearch InertSustain AQ-C18 -
LB944 - Analysis of Amikacin sulfate -
LC InertSearch InertSustainSwift C18 -
LB943 - Analysis of Amikacin -
LC InertSearch InertSustainSwift C18 -
LB940 - Analysis of DL-Malic acid -
LC InertSearch InertSustain C18 -
LB938 - Analysis of Galantamine -
LC InertSearch InertSustain C18 -
LB935 - Analysis of Febuxostat -
LC InertSearch InertSustain AQ-C18 -
LB934 - Analysis of Methylpyrazines -
LC InertSearch InertSustain C18 -
LB930 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB929 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB928 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB927 - Analysis of Blonanserin -
LC InertSearch InertSustain C18 -
LB922 - Analysis of 4 Drugs -
LC InertSearch InertSustai AQ-C18 InertSustain AQ-C18 -
LB920 - Analysis of Triphenylphosphine oxide -
LC InertSearch InertSustain C18 -
LB918 - Analysis of d-α-Tocopheryl Acetate -
LC InertSearch InertSustain C18 -
LB917 - Analysis of 130 Pestisides -
LC InertSearch InertSustain C18 -
LB916 - Analysis of Metformin Hydrochloride -
LC InertSearch InertSustain C18 -
LB915 - Analysis of Metformin Hydrochloride -
LC InertSearch InertSustain C18 -
LB910 - Analysis of Fatty acids (C18-C26) -
LC InertSearch InertSustain AQ-C18 -
LB909 - Analysis of Fatty acids (C18-C26) -
LC InertSearch InertSustain AQ-C18 -
LB908 - Analysis of Fatty acids (C1-C18) -
LC InertSearch InertSustain AQ-C18 -
LB907 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB906 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB905 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB903 - Analysis of Perospirone hydrochloride -
LC InertSearch InertSustain C18 -
LB902 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB901 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 -
LB899 - Analysis of Fesoterodine Fumarate -
LC InertSearch InertSustainSwift C18 -
LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -
LC InertSearch InertSustain AQ-C18 -
LB896 - Analysis of Triptorelin Pamoate -
LC InertSearch InertSustain C18 -
LB892 - Analysis of Chlorophenols -
LC InertSearch InertSustain C18 HP -
LB891 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 HP -
LB890 - Analysis of Saxagliptin -
LC InertSearch InertSustain C18 HP -
LB886 - Analysis of Glyphosate,Mecoprop,Bromacil -
LC InertSearch InertSustain AX-C18 -
LB885 - Analysis of Voriconazole -
LC InertSearch InertSustain C18 -
LB884 - Analysis of Voriconazole -
LC InertSearch InertSustain C18 -
LB882 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch InertSustain C18 -
LB880 - Analysis of Paracetamol and Mefenamic acid -
LC InertSearch InertSustain C18 -
LB878 - Analysis of Mefenamic acid -
LC InertSearch InertSustain C18 -
LB876 - Analysis of Cefoxitin -
LC InertSearch InertSustain C18 -
LB874 - Analysis of Captopril and Captopril Disulfide -
LC InertSearch InertSustain AQ-C18 -
LB873 - Tacrolimus Extended-Release Capsules -
LC InertSearch InertSustain AQ-C18 -
LB868 - Analysis of Propionic Acid -
LC InertSearch InertSustain C18 -
LB867 - Analysis of Febuxostat -
LC InertSearch InertSustain C18 -
LB866 - Analysis of Sucralose -
LC InertSearch InertSustain C18 -
LB865 - Analysis of Water-soluble vitamins and D-Araboascorbic acid -
LC InertSearch InertSustain C18 -
LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -
LC InertSearch InertSustain C18 -
LB863 - Analysis of BHT_BHA_PG（Analytical Method A） -
LC InertSearch InertSustain C18 -
LB862 - Analysis of Antioxidants -
LC InertSearch InertSustain C18 -
LB860 - Analysis of Glycyrrhizinate acid -
LC InertSearch InertSustain C18 -
LB858 - Analysis of Natamycin (Analytical Method B) -
LC InertSearch InertSustain C18 -
LB857 - Analysis of Natamycin (Analytical Method A) -
LC InertSearch InertSustain AQ-C18 -
LB855 - Analysis of 6 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C30 -
LB854 - Analysis of Naringin and Hesperidin -
LC InertSearch InertSustain AQ-C18 -
LB853 - Analysis of p-Hydroxybenzoic acid esters -
LC InertSearch InertSustain C18 -
LB852 - Analysis of Benzoic acid -
LC InertSearch InertSustain C18 -
LB851 - Analysis of Calcium Pantothenate -
LC InertSearch InertSustain AQ-C18 -
LB850 - Analysis of Ethylenediaminetetraacetic acid ferric sodium salt trihydrate -
LC InertSearch InertSustain C18 -
LB846 - Analysis of Tocopheryl acetate -
LC InertSearch InertSustain C18 -
LB845 - Analysis of L-Ascorbyl palminate and L-Ascorbic Stearate -
LC InertSearch InertSustain C18 -
LB835 - Analysis of Sudan dyes and Para red -
LC InertSearch InertSustain C18 -
LB834 - Analysis of Paraoxybenzoic acid esters -
LC InertSearch InertSustain C18 -
LB833 - Analysis of Methyl Parahydroxybenzoate -
LC InertSearch InertSustain C18 -
LB832 - Analysis of Nordihydroguaiaretic Acid -
LC InertSearch InertSustain C18 -
LB831 - Analysis of Nordihydroguaiaretic Acid -
LC InertSearch InertSustain C18 -
LB830 - Analysis of Azoxystrobin -
LC InertSearch InertSustain C18 -
LB828 - Analysis of Chloroprocaine Hydrochloride -
LC InertSearch InertSustain C18 -
LB827 - Analysis of Clobetasone butyrate standard -
LC InertSearch InertSustainSwift C18 -
LB826 - Analysis of Nicotinic acid and Nicotinamide (Under the Condition of food additive analysis method in food) -
LC InertSearch InertSustain C18 -
LB824 - Analysis of kojic acid -
LC InertSearch InertSustain C18 -
LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB818 - Analysis of Nucleotides and Cyclic nucleotides -
LC InertSearch InertSustain AX-C18 -
LB817 - Analysis of Phospholipids -
LC InertSearch InertSustainSwift C18 -
LB816 - Analysis of Zoledronic acid -
LC InertSearch InertSustainSwift C18 -
LB815 - Analysis of Riboflavin (Vitamin B2) and its metabolites -
LC InertSearch InertSustainSwift C18 -
LB814 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AQ-C18 -
LB813 - Analysis of Fosetyl and Glyphosate -
LC InertSearch InertSustain AQ-C18 -
LB812 - Analysis of Dehydroacetic acid -
LC InertSearch InertSustain C18 -
LB809 - Analysis of ATP related compounds and Guanylic acid -
LC InertSearch InertSustain AQ-C18 -
LB805 - Analysis of nonvolatile amines (prelabel derivatization by Dansyl Chloride) -
LC InertSearch InertSustain C18 -
LB800 - Analysis of 1,3-Dicyclohexylurea -
LC InertSearch InertSustain C18 -
LB789 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB788 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB787 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB786 - Analysis of Oligonucleotides -
LC InertSearch InertSustain AX-C18 -
LB785 - Analysis of Uric Acid and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB784 - Analysis of ATP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB783 - Analysis of UTP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB782 - Analysis of GTP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB781 - Analysis of CTP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB780 - Analysis of ATP and its related compounds -
LC InertSearch InertSustain AX-C18 -
LB779 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AX-C18 -
LB778 - Analysis of Coenzyme A (CoA) -
LC InertSearch InertSustain AX-C18 -
LB777 - Analysis of Sugar Phosphates -
LC InertSearch InertSustain AX-C18 -
LB776 - Analysis of Sugar Phosphates -
LC InertSearch InertSustain AX-C18 -
LB775 - Analysis of Cyclic Nucleotide -
LC InertSearch InertSustain AX-C18 -
LB774 - Analysis of Nucleotide sugars -
LC InertSearch InertSustain AX-C18 -
LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -
LC InertSearch InertSustain AX-C18 -
LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -
LC InertSearch InertSustain AX-C18 -
LB771 - Analysis of Nucleoside and Nucleic acid base -
LC InertSearch InertSustain AX-C18 -
LB770 - Analysis of Pyruvic acid and Phosphoenolpyruvic acid -
LC InertSearch InertSustain AX-C18 -
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -
LC InertSearch InertSustain AX-C18 -
LB768 - Analysis of Low molecular weight Hyaluronic acid -
LC InertSearch InertSustain AX-C18 -
LB767 - Analysis of Chondroitin Sulfate -
LC InertSearch InertSustain AX-C18 -
LB766 - Analysis of Glucuronic acid -
LC InertSearch InertSustain AX-C18 -
LB765 - Analysis of Sialic acid -
LC InertSearch InertSustain AX-C18 -
LB764 - Analysis of Organic acids -
LC InertSearch InertSustain AX-C18 -
LB763 - Analysis of Tryptophan metabolites -
LC InertSearch InertSustain AX-C18 -
LB762 - Analysis of L-Cysteic acid -
LC InertSearch InertSustain AX-C18 -
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain C18 -
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain AX-C18 -
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -
LC InertSearch InertSustain C18 -
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -
LC InertSearch InertSustainSwift C18 -
LB745 - Analysis of of Metformin Hydrochloride Tablets（Under the Condeition of USP43-NF38, Glyburide and Metformin Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB738 - Analysis of Remdesivir -
LC InertSearch InertSustain AX-C18 -
LB737 - Analysis of Favipiravir -
LC InertSearch InertSustain AX-C18 -
LB736 - Analysis of Antidepressants -
LC InertSearch InertSustain AX-C18 -
LB735 - Analysis of Antihistamines -
LC InertSearch InertSustain AX-C18 -
LB734 - Analysis of components of coffee -
LC InertSearch InertSustain AX-C18 -
LB733 - Analysis of Water-soluble Vitamins -
LC InertSearch InertSustain AX-C18 -
LB732 - Analysis of Peptides -
LC InertSearch InertSustain AX-C18 -
LB731 - Analysis of Peptides -
LC InertSearch InertSustain AX-C18 -
LB730 - Analysis of Glutathione -
LC InertSearch InertSustain AX-C18 -
LB729 - Analysis of L-Cystine and L-Cysteine and L-Cysteic acid -
LC InertSearch InertSustain AX-C18 -
LB728 - Analysis of Taurine (2-Aminoethanesulfonic acid) -
LC InertSearch InertSustain AX-C18 -
LB727 - Analysis of Aspartic acid and Glutamic acid -
LC InertSearch InertSustain AX-C18 -
LB726 - Analysis of Carbocisteine -
LC InertSearch InertSustain AX-C18 -
LB725 - Analysis of Glyceric acid -
LC InertSearch InertSustain AX-C18 -
LB724 - Analysis of Glyphosate and Glufosinate -
LC InertSearch InertSustain AX-C18 -
LB723 - Analysis of Insulin Chain B Oxidized -
LC InertSearch InertSustain AX-C18 -
LB722 - Analysis of Ethenzamide -
LC InertSearch InertSustain C18 -
LB721 - Analysis of Acetaminophen -
LC InertSearch InertSustain C18 -
LB720 - Analysis of Acetylsalicilic acid -
LC InertSearch InertSustain C18 -
LB716 - Analysis of Toluene and Toluene d8 -
LC InertSearch InertSustain C18 -
LB715 - Analysis of Toluene and Toluene d8 -
LC InertSearch InertSustainSwift C18 -
LB711 - Analysis of Underivatized Glyphosate, Glufosinate and Other Polar Pesticides -
LC InertSearch InertSustain AX-C18 -
LB710 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain C18 HP -
LB709 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB708 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB707 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB706 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB705 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -
LC InertSearch InertSustain AQ-C18 -
LB704 - Analysis of Phosphate ester flame retardants (PFRs) -
LC InertSearch InertSustainSwift C18 -
LB703 - Analysis of Phosphate ester flame retardants (PFRs) -
LC InertSearch InertSustainSwift C18 -
LL041 - Analysis of cannabinoids -
LC InertSearch InertSustain Phenylhexyl HP -
LL040 - Analysis of cannabinoids -
LC InertSearch InertSustain Phenylhexyl -
LL039 - Analysis of cannabinoids -
LC InertSearch InertSustainSwift C18 -
LL038 - Analysis of cannabinoids -
LC InertSearch InertSustainSwift C18 -
LL037 - Analysis of cannabinoids -
LC InertSearch InertSustain C18 -
LB702 - Analysis of ibuprofen -
LC InertSearch InertSustain C18 -
LB700 - Analysis of acetaminophen -
LC InertSearch InertSustain C18 -
LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -
LC InertSearch InertSustain C18 -
LB696 - Analysis of Trifluoroacetic acid -
LC InertSearch InertSustain AQ-C18 -
LB695 - Analysis of acetic acid （USP） -
LC InertSearch InertSustainSwift C18 -
LB692 - Analysis of Nitrosamines -
LC InertSearch InertSustain AQ-C18 -
LB689 - Analysis of Capsaicin in red pepper (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB688 - Analysis of Red pepper extract -
LC InertSearch InertSustain C18 -
LB686 - Analysis of Chlorogenic acid -
LC InertSearch InertSustain AX-C18 -
LB682 - Analysis of Acetic acid and Acetic anhydride -
LC InertSearch InertSustainSwift C18 -
LB680 - Analysis of bromate -
LC InertSearch InertSustain C18 -
LB679 - Analysis of Cetylpyridinium chloride -
LC InertSearch InertSustain AX-C18 -
LB678 - Analysis of Validamycin -
LC InertSearch InertSustain C18 HP -
LB677 - Analysis of Zebularine and Gemcitabine -
LC InertSearch InertSustain C18 HP -
LB673 - Analysis of Limonene -
LC InertSearch InertSustain C18 -
LB669 - Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) -
LC InertSearch InertSustainSwift C18 -
LL033 - Analysis of Phospholipids -
LC InertSearch InertSustain C18 -
LB656 - Analysis of Peptides -
LC InertSearch InertSustain AQ-C18 -
LB655 - Analysis of Peptides -
LC InertSearch InertSustain C18 -
LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -
LC InertSearch InertSustain C18 -
LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -
LC InertSearch InertSustain C18 -
LB639 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -
LC InertSearch InertSustainSwift C18 -
LB638 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -
LC InertSearch InertSustain C18 -
LB636 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) -
LC InertSearch InertSustainSwift C18 -
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -
LC InertSearch InertSustain AQ-C18 HP -
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -
LC InertSearch InertSustainSwift C18 -
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -
LC InertSearch InertSustainSwift C18 -
LB626 - Analysis of Prasugrel hydrochloride -
LC InertSearch InertSustain C18 -
LB625 - Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) -
LC InertSearch InertSustainSwift C18 -
LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -
LC InertSearch InertSustain C18 -
LB620 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) -
LC InertSearch InertSustain C18 -
LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -
LC InertSearch InertSustain C8 -
LB618 - Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) -
LC InertSearch Inertsil ODS-3 -
LB613 - Analysis of Isopropylmethylphenol -
LC InertSearch InertSustain AQ-C18 -
LT168 - Simultaneous analysis of pesticides in tap water using LC-MS/MS -
LC Technical Note InertSustain C18 HP InertSustain C18 Guard Column for UHPLC -
LT166 - Simultaneous Analysis of 12 Soybean Isoflavones -
LC Technical Note InertSustainSwift C18 -
LT163 - Analysis of UV Absorbers in Cosmetic Products -
LC Technical Note InertSustain C18 -
LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -
LC Technical Note InertSustain AQ‐C18 HP -
LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -
LC Technical Note InertSustain C18 -
LT157 - Examination of Loading Capacity of Proteins Using MonoSpin C18 -
LC Technical Note InertSustainBio C18 -
LT156 - Sample Preparation of Peptides and Proteins Using MonoSpin C18 -Obtain High Recovery with Ethanol Elution- -
LC Technical Note InertSustainBio C18 -
LT155 - Metal-free Columns for HPLC Part2 -
LC Technical Note InertSustain C18 PEEK Column -
LT152 - Metal-free Columns for HPLC Part 1 -
LC Technical Note InertSustainSwift C18 InertSustain C18 PEEK Column -
LT135 - Simultaneous Analysis of Tap Water Pesticides by LC/MS/MS -
LC Technical Note InertSustain C18 -
LT130 - Analysis of Anion Surfactants by LC/MS/MS -
LC Technical Note InertSustain C18 HP Inertsil C8-4 HP -
LT124 - Analysis of Furfural in Insulating Oil -
LC Technical Note InertSustainSwift C18 InertSustain AQ-C18 -
LT108 - Simultaneous Analysis of Organic Fluorine Compounds Using LC/MS/MS -
LC Technical Note InertSustain C18 -
LT107 - Simultaneous LC/MS/MS Analysis of Pesticides Used in Golf Courses -
LC Technical Note InertSustain C18 -
LT100 - Inertsil HPLC Columns for Reversed Phase Separation (2) -
LC Technical Note InertSustain C18 Inertsil ODS-4 Inertsil ODS-3 Inertsil ODS-2 Inertsil ODS-SP Inertsil ODS-EP Inertsil ODS-P Inertsil WP300 C18 InertSustain C8 Inertsil C8-3 Inertsil C8-4 Inertsil WP300 C8 InertSustain Phenyl Inertsil Ph-3 Inertsil Ph -
LT099 - Analysis of Valsartan -
LC Technical Note InertSustain C18 -
LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -
LC Technical Note InertSustain AQ-C18 Inertsil ODS-4 -
LL030 - Simultaneous analysis of bile acids using LCMSMS -
LC InertSearch InertSustain C18 -
LL029 - Simultaneous analysis of lipid mediators using LC/MS/MS -
LC InertSearch InertSustain C18 -
LL027 - Analysis of Isothiazolinone preservatives -
LC InertSearch InertSustain AQ-C18 -
LL023 - Analysis of Triclosan -
LC InertSearch InertSustain C18 -
LL022 - Analysis of Catechins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LL019 - Analysis of Food Colorants (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LL017 - Analysis of Food Colorants (InertSustain C18) -
LC InertSearch InertSustain C18 -
LL015 - Simultaneous analysis of metabolites using LCMSMS (5) - compounds related to central metabolism part 2 - -
LC InertSearch InertSustain C18 -
LL014 - Simultaneous analysis of metabolites using LCMSMS (4) - compounds related to central metabolism part 1 - -
LC InertSearch InertSustain C18 -
LL013 - Simultaneous analysis of metabolites using LC/MS/MS (3) - nucleobases and their related compounds part 2 - -
LC InertSearch InertSustain C18 -
LL012 - Simultaneous analysis of metabolites using LC/MS/MS (2) - nucleobases and their related compounds part 1 - -
LC InertSearch InertSustain C18 -
LL011 - Simultaneous analysis of metabolites using LC/MS/MS (1) - amino acids and their related compounds - -
LC InertSearch InertSustain C18 -
LB568 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -
LC InertSearch InertSustain AQ-C18 -
LB566 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -
LC InertSearch InertSustain AQ-C18 -
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -
LC InertSearch InertSustain AQ-C18 -
LB561 - Analysis of Neotame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -
LC InertSearch InertSustain AQ-C18 -
LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -
LC InertSearch InertSustain AQ-C18 -
LB559 - Analysis of Artificial sweeteners -
LC InertSearch InertSustain AQ-C18 -
LB556 - Analysis of Mirtazapine -
LC InertSearch InertSustain C18 -
LB554 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Orally Disintegrating Tablets) -
LC InertSearch InertSustainSwift C18 -
LB553 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Tablets) -
LC InertSearch InertSustain C18 -
LB552 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine) -
LC InertSearch InertSustain C18 -
LB551 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -
LC InertSearch InertSustainSwift C18 -
LB550 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -
LC InertSearch InertSustainSwift C18 -
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -
LC InertSearch InertSustainSwift C18 -
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -
LC InertSearch InertSustainSwift C18 -
LB544 - Analysis of Catecholamines -
LC InertSearch InertSustain AQ-C18 -
LB536 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -
LC InertSearch InertSustain C18 -
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -
LC InertSearch InertSustain C18 -
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -
LC InertSearch InertSustain C18 -
LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -
LC InertSearch InertSustain C18 -
LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -
LC InertSearch InertSustain C18 -
LB522 - Analysis of Glutathione and its related compounds -
LC InertSearch InertSustain AQ-C18 -
LB521 - Analysis of Folic acid -
LC InertSearch InertSustain C18 -
LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -
LC InertSearch InertSustain C18 -
LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -
LC InertSearch InertSustainSwift C18 -
LB518 - Analysis of Glycyrrhetinic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Monoammonium α-Glycyrrhizinate) -
LC InertSearch InertSustain C18 -
LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -
LC InertSearch InertSustain C18 -
LB516 - (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -
LC InertSearch InertSustain C18 -
LB515 - Analysis of Caffeine (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -
LC InertSearch InertSustain C18 -
LB514 - Analysis of Oligonucleotides -
LC InertSearch InertSustainSwift C18 -
LB513 - Analysis of Peptide hormones -
LC InertSearch InertSustainBio C18 -
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -
LC InertSearch InertSustain C18 -
LB511 - Analysis of Parabens, Estradiol and Progesterone -
LC InertSearch InertSustainSwift C18 -
LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -
LC InertSearch InertSustainSwift C18 -
LB509 - Analysis of Angiotensin -
LC InertSearch InertSustainBio C18 -
LB507 - Analysis of Fatty acids by LC/MS/MS -
LC InertSearch InertSustain AQ-C18 -
LB506 - Analysis of Neonicotinoids -
LC InertSearch InertSustain C18 -
LB504 - Analysis of Fipronil -
LC InertSearch InertSustainSwift C18 -
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -
LC InertSearch InertSustain C18 -
LB488 - Analysis of Sucralose -
LC InertSearch InertSustain C18 -
LB487 - Analysis of Verapamil Hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Verapamil Hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB485 - Analysis of Pyridoxal Phosphate Hydrate (Under the Condition of the Japanese Pharmacopoeia, (4) Related subatances) -
LC InertSearch InertSustain AQ-C18 -
LB484 - Analysis of Catecholamine metabolite -
LC InertSearch InertSustainSwift C18 -
LB483 - Analysis of Minocycline Hydrochloride (Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustainSwift C8 -
LB480 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LB470 - Simultaneous analysis of Amino acids derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) -
LC InertSearch InertSustainSwift C18 -
LB465 - Analysis of Fungicides -
LC InertSearch InertSustain C18 -
LB464 - Analysis of Ultraviolet absorbers -
LC InertSearch InertSustain C18 -
LB462 - Analysis of Cephalexin (Under the Condition of USP 39-NF34) -
LC InertSearch InertSustain C18 -
LB461 - Analysis of Phenylephrine Hydrochloride (Under the Condition of USP 39-NF34, Phenylephrine Hydrochloride Injection) -
LC InertSearch InertSustain C18 -
LB457 - Analysis of Hydroxynaphthoquinones -
LC InertSearch InertSustain C18 -
LB456 - Analysis of Benzenediols -
LC InertSearch InertSustain C18 -
LB455 - Analysis of Polar Peptides -
LC InertSearch InertSustain AQ-C18 -
LB452 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Tablets) -
LC InertSearch InertSustain AQ-C18 -
LB451 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain AQ-C18 -
LB450 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain AQ-C18 -
LB449 - Analysis of Lansoprazole(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -
LC InertSearch InertSustain C8 -
LB447 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (6) 2-Aminophenol and 4-Aminophenol) -
LC InertSearch InertSustainSwift C18 HP -
LB443 - Analysis of Nucleotide -
LC InertSearch InertSustain AQ-C18 -
LB441 - Analysis of Aflatoxin M1(InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB440 - Analysis of Myoglobin Digests (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB439 - Analysis of Myoglobin Digests (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB438 - Analysis of BSA Digests (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB437 - Analysis of BSA Digests (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB436 - Analysis of Mesalazine(Under the Condition of the Japanese Pharmacopoeia, (7) Aniline) -
LC InertSearch InertSustain C18 -
LB435 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (6) 2-Pyrrolidone) -
LC InertSearch InertSustain AQ-C18 -
LB433 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (4) 1-Vinyl-2-pyrrolidone) -
LC InertSearch InertSustain AQ-C18 -
LB430 - Analysis of Tulobuterol Hydrochloride(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB429 - Analysis of Tulobuterol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB428 - Analysis of Zonisamide -
LC InertSearch InertSustain AQ-C18 -
LB427 - Analysis of Zonisamide -
LC InertSearch InertSustain AQ-C18 -
LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB425 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -
LC InertSearch InertSustain C18 -
LB422 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain C18） -
LC InertSearch InertSustain C18 -
LB420 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustainSwift C18） -
LC InertSearch InertSustainSwift C18 -
LB419 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustain C18） -
LC InertSearch InertSustain C18 -
LB417 - Analysis of Vitamin K (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB416 - Analysis of Vitamin K (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB414 - Analysis of Esomeprazole magnesium (Under the Condition of USP 38-NF33, Esomeprazole magnesium Extended-release Tablets) -
LC InertSearch InertSustain C18 -
LB413 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 -
LB412 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 -
LB408 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 -
LB406 - Analysis of Hippuric acid -
LC InertSearch InertSustain AQ-C18 HP -
LB405 - Analysis of Phenolic antioxidants -
LC InertSearch InertSustainSwift C18 -
LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB400 - Analysis of 9 Drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB399 - Analysis of 9 Drugs (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB397 - Analysis of Glyphosate, Glufosinate and AMPA derivatized with 9-Fluorenylmethyl Chloroformate (FMOC) -
LC InertSearch InertSustainSwift C18 -
LB396 - Analysis of Oligonucleotide -
LC InertSearch InertSustainBio C18 -
LB395 - Analysis of Acetaminophen and Caffeine -
LC InertSearch InertSustainSwift C18 -
LB394 - Analysis of Methacrylic acid (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB393 - Analysis of Methacrylic acid (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB392 - Analysis of Methacrylic acid (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB389 - Analysis of 12 Drugs (InertSustainSwift C18 HP) -
LC InertSearch InertSustainSwift C18 HP -
LB388 - Analysis of 12 Drugs (InertSustain C18 HP) -
LC InertSearch InertSustain C18 HP -
LB387 - Analysis of 12 Drugs (InertSustain AQ-C18 HP) -
LC InertSearch InertSustain AQ-C18 HP -
LB383 - Analysis of Angiotensin II receptor blockers (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB382 - Analysis of Angiotensin II receptor blockers (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB380 - Analysis of ATP related compounds -
LC InertSearch InertSustain AQ-C18 -
LB378 - Analysis of Hippuric Acids -
LC InertSearch InertSustain AQ-C18 HP -
LB377 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain AQ-C18 HP -
LB375 - Analysis of Lidocaine -
LC InertSearch InertSustain C18 -
LB373 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -
LC InertSearch InertSustainSwift C18 -
LB372 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -
LC InertSearch InertSustainSwift C18 -
LB371 - Analysis of Amlodipine besilate (Under the Condition of the Japanese Pharmacopoeia, Amlodipine Besilate Orally Disintegrating Tablets) -
LC InertSearch InertSustainSwift C18 -
LB368 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB367 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB366 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB365 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB364 - Analysis of Water-soluble Vitamins -
LC InertSearch InertSustain AQ-C18 -
LB363 - Analysis of Organic acid -
LC InertSearch InertSustain AQ-C18 -
LB362 - Analysis of β-blocker -
LC InertSearch InertSustain AQ-C18 -
LB361 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain AQ-C18) -
LC InertSearch InertSustain AQ-C18 -
LB360 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia, Roxithromycin Tablets) -
LC InertSearch InertSustain C18 -
LB359 - Analysis of EPA and DHA -
LC InertSearch InertSustain C18 -
LB358 - Analysis of EPA and DHA (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB355 - Analysis of 7 fatty acids -
LC InertSearch InertSustain C18 -
LB354 - Analysis of 7 fatty acids -
LC InertSearch InertSustain C18 -
LB353 - Analysis of 7 fatty acids -
LC InertSearch InertSustain C18 -
LB352 - Analysis of 7 fatty acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB349 - Analysis of Sodium Propionate (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB342 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB341 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB340 - Analysis of Chelating compounds -
LC InertSearch InertSustain C18 -
LB339 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia, Rebamipide Tablets) -
LC InertSearch InertSustain C18 -
LB337 - Analysis of Glyphosate, Glufosinate and AMPA derivatized with 9-Fluorenylmethyl Chloroformate (FMOC) -
LC InertSearch InertSustain C18 -
LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB318 - Analysis of Maleic acid, Fumaric acid and Acrylic acid (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -
LC InertSearch InertSustain C18 -
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -
LC InertSearch InertSustain C18 -
LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB290 - Analysis of Cefalexin (Under the Condition of the Japanese Pharmacopoeia, Cefalexin Combination Granules) -
LC InertSearch InertSustain C18 -
LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB283 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB271 - Analysis of Tulathromycin -
LC InertSearch InertSustainSwift C18 -
LB270 - Analysis of β-blocker -
LC InertSearch InertSustainSwift C18 -
LB269 - Analysis of Tetracyclines (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB268 - Analysis of Tetracyclines (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB260 - Analysis of Chlorophenol -
LC InertSearch InertSustain C18 HP -
LB256 - Analysis of Nucleobase (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -
LC InertSearch InertSustain C18 -
LB247 - Analysis of Terbinafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Terbinafine hydrochloride Cream) -
LC InertSearch InertSustainSwift C18 -
LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -
LC InertSearch InertSustainSwift C18 -
LB234 - Analysis of Amino acids -
LC InertSearch InertSustainSwift C18 -
LB233 - Analysis of Amino acids -
LC InertSearch InertSustainSwift C18 -
LB232 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 HP -
LB231 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 HP -
LB230 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustainSwift C18 HP -
LB228 - Analysis of Polyvinyl alcohol, Polyethyleneglycol and Graft copolymer (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), (3) Acetic acid) -
LC InertSearch InertSustain C18 -
LB224 - Analysis of Tocopherol (InertSuatin C18) (Under the Condition of the Japanese Pharmaceutical Codex) -
LC InertSearch InertSustain C18 -
LB222 - Analysis of Butenafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 HP -
LB211 - Analysis of 2 kinds of Aldehydes (InertSustain C18) (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LB210 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB209 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -
LC InertSearch InertSustain C18 -
LB196 - Analysis of Ciprofloxacin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ciprofloxacin hydrochloride hydrate) -
LC InertSearch InertSustain C18 -
LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -
LC InertSearch InertSustain C18 -
LB186 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -
LC InertSearch InertSustain C18 -
LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -
LC InertSearch InertSustain C18 -
LB183 - Analysis of Phellodendron Bark (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB182 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB177 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) -
LC InertSearch InertSustain C18 -
LB176 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) -
LC InertSearch InertSustain C18 -
LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -
LC InertSearch InertSustain C18 -
LB173 - Analysis of Azelastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB167 - Analysis of Crospovidone (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB159 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB157 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB151 - Analysis of Liner alkylbenzene sulfonate (InertSustain C18 HP) -
LC InertSearch InertSustain C18 HP -
LB149 - Analysis of Liner alkylbenzene sulfonate (InertSustain C18 HP) -
LC InertSearch InertSustain C18 HP -
LB130 - Analysis of Amantadine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB114 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB112 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB109 - Analysis of Organic acids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB107 - Analysis of Pre-column Derivatized Aflatoxin -
LC InertSearch InertSustain C18 -
LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -
LC InertSearch InertSustain C18 -
LB086 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -
LC InertSearch InertSustain C18 -
LB076 - Analysis of 4 Pesticides (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB075 - Analysis of Venlafaxine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB074 - Analysis of Rabeprazol (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB071 - Analysis of Esomeprazol (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB070 - Analysis of 13 drugs for NSAIDs -
LC InertSearch InertSustain C18 -
LB069 - Analysis of Rosuvastatin Calcium -
LC InertSearch InertSustain C18 -
LB068 - Analysis of Olmesartan medoxomil -
LC InertSearch InertSustain C18 -
LB067 - Analysis of Aripiprazole -
LC InertSearch InertSustain C18 -
LB066 - Analysis of Mosapride Citrate Tablets (Under the Condition of Japanese Pharmacopoeia 16) -
LC InertSearch InertSustain C18 -
LB063 - Analysis of Tranilast (InertSustain C18)(Under the Condition of the Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -
LC InertSearch InertSustain C18 -
LB052 - Analysis of Valsartan (Inertsil ODS-4) -
LC InertSearch InertSustain C18 -
LB042 - Analysis of 18Drugs(InertSustain C18 2um) -
LC InertSearch InertSustain C18 -
LB039 - Analysis of Phospholipids (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB038 - Analysis of Chlorantraniliprole (InertSustain C18) -
LC InertSearch InertSustain C18 -
LB035 - Analysis of Terbinafine HCl (InertSustain C18) (Under the Condition of Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LB029 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB028 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB027 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB026 - Analysis of Pitavastatin Calcium -
LC InertSearch InertSustain C18 -
LB025 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Hydrate) -
LC InertSearch InertSustain C18 -
LB024 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -
LC InertSearch InertSustain C18 -
LB023 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -
LC InertSearch InertSustain C18 -
LB022 - Analysis of Losartan potassium and Valsartan -
LC InertSearch InertSustain C18 -
LB021 - Analysis of Valsartan and Hydrochlorothiazide -
LC InertSearch InertSustain C18 -
LB018 - Analysis of Potassium ferricyanide and Potassium ferrocyanide -
LC InertSearch InertSustain C18 -
LB016 - Analysis of Iminoctadine -
LC InertSearch InertSustain C18 -
LB014 - Analysis of Ergosterol(InertSustain C18) -
LC InertSearch InertSustain C18 -
LB013 - Analysis of Iohexol and Iopamidol -
LC InertSearch InertSustain C18 -
LA998 - Analysis of 5 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA997 - Analysis of 5 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA995 - Analysis of Fexofenadine hydrochloride (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA992 - Analysis of Spiramycins in Beef -
LC InertSearch InertSustain C18 -
LA991 - Analysis of Spiramycins -
LC InertSearch InertSustain C18 -
LA985 - Analysis of Proteins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA981 - Analysis of 5-Aminoisophthalic acid -
LC InertSearch InertSustain C18 -
LA980 - Analysis of Oxine-copper -
LC InertSearch InertSustain C18 -
LA978 - Analysis of Tolcloｆos-methyl -
LC InertSearch InertSustain C18 -
LA977 - Analysis of Recerpine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA973 - Analysis of Non-ionic surfactant(Detected by Pre-Column complexation with Co-PAR) -
LC InertSearch InertSustain C18 -
LA972 - Analysis of Loxoprofen- InertSustain C18(Under the Condition of Japanese Pharmacopoeia) -
LC InertSearch InertSustain C18 -
LA969 - Analysis of Antioxidant(BHT) -
LC InertSearch InertSustain C18 -
LA966 - Analysis of Valsartan (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA965 - Analysis of DNPH Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA964 - Analysis of DNPH Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA962 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA961 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA960 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA959 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA958 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA956 - Analysis of Glutathione HPLC-ECD -
LC InertSearch InertSustain C18 -
LA955 - Analysis of Parabens (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA952 - Analysis of Parabens (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA949 - Analysis of Histamine and Thiamne (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA947 - Analysis of Parabens (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA943 - Analysis of Azithromycin -
LC InertSearch InertSustain C18 -
LA935 - Analysis of Alcohols HPLC-ECD -
LC InertSearch InertSustain C18 -
LA934 - Analysis of Diquat and Paraquat -
LC InertSearch InertSustain C18 -
LA930 - Analysis of Cold medicine (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA929 - Analysis of Acetylsalicylic acid (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA920 - Analysis of Levofolinate calcium -
LC InertSearch InertSustain C18 -
LA919 - Analysis of Levofolinate calcium -
LC InertSearch InertSustain C18 -
LA918 - Analysis of carbamate insecticides - Inertsil ODS-4(Ditected by post-column method with OPA) -
LC InertSearch Inertsil ODS-4 -
LA917 - Analysis of carbamate insecticides - Inertsil ODS-3(Ditected by post-column method with OPA) -
LC InertSearch Inertsil ODS-3 -
LA916 - Analysis of carbamate insecticides - InertSustain C18(Ditected by post-column method with OPA) -
LC InertSearch InertSustain C18 -
LA914 - Analysis of Carbamate insecticides - InertSustain C18(Directed by Post-Column Method with OPA) -
LC InertSearch InertSustain C18 -
LA913 - Analysis of 9 kinds of Pesticides for Golf Course(InertSustain C18) -
LC InertSearch InertSustain C18 -
LA912 - Analysis of 9 kinds of Pesticides for Golf Course(InertSustain C18) -
LC InertSearch InertSustain C18 -
LA910 - Analysis of 13 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -
LC InertSearch InertSustain C18 -
LA909 - Analysis of Indometacin (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA906 - Analysis of Licorice extract (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA905 - Analysis of Glycyrrhiza Standard (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA904 - Analysis of Bilberry extract (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA903 - Analysis of Basic drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA902 - Analysis of Basic drugs (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA895 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA893 - Analysis of Fat-soluble Vitamins (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA892 - Analysis of Vitamin K (InertSustain C18) -
LC InertSearch InertSustain C18 -
LA891 - Analysis of Phytosterol (InertSustain C18) -
LC InertSearch InertSustain C18 HP -
LA890 - Analysis of Basic Drugs (InertSustain C18) -
LC InertSearch InertSustain C18 HP -
LA889 - Analysis of Basic Drugs (InertSustain C18) -
LC InertSearch InertSustain C18 HP -
LA522 - Analysis of Resveratrol -
LC InertSearch InertSustain C18